The findings of a new study suggest five percent of Tepezza users require a second treatment course of the thyroid eye disease drug, raising questions as to whether those patients…
A product liability lawsuit claims the side effects of Tepezza, a thyroid eye disease drug, led to permanent hearing loss.
A new study finds that most Tepezza patients suffer some degree of hearing loss, and a third of those may not recover their hearing.
The manufacturers of the thyroid eye disease drug Tepezza are calling for a lawsuit over hearing loss complications to be dismissed due to federal preemption laws.
The new thyroid eye disease drug, Tepezza, is linked to an increased risk of hearing problems, according to the findings of a new study.
